Epigenetic silencing of IGFBPL1 promotes esophageal cancer growth by activating PI3K-AKT signaling

Liu Yingge(Chinese PLA General Hospital), Mingzhou Guo(Chinese PLA General Hospital)
Clinical Epigenetics
February 10, 2020
10.1186/s13148-020-0815-x
Cited by 29

Related Papers

Silencing DACH1 Promotes Esophageal Cancer Growth by Inhibiting TGF-β Signaling
|PLoS ONE|2014|47
Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling
|Journal of Thoracic Oncology|2016|44
Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma
|Clinical Epigenetics|2018|36
Methylation of NRN1 is a novel synthetic lethal marker of PI3K‐Akt‐mTOR and ATR inhibitors in esophageal cancer
|Cancer Science|2021|32
Epigenetic silencing of <i>KCTD8</i> promotes hepatocellular carcinoma growth by activating PI3K/AKT signaling
|Epigenomics|2024|2